Frontcourt Group

Aria CV, Inc. is a medical device company based in St. Paul, Minnesota, specializing in treatments for pulmonary arterial hypertension (PAH). Founded in 2010 by Drs. John Scandurra and Karl Vollmers, the company has developed an innovative implantable cardiovascular device aimed at reducing the workload on the right side of the heart. This device holds the potential to enhance both the survival and quality of life for patients suffering from pulmonary hypertension. Aria CV has secured an exclusive license for certain patents from the University of Minnesota, reflecting its commitment to advancing medical technology in this critical area of healthcare.

SPR Therapeutics, LLC is a medical device company based in Cleveland, Ohio, specializing in the development and commercialization of interventional pain management therapies. The company focuses on peripheral nerve stimulation (PNS) systems, with its flagship product being the Smartpatch, a minimally invasive device designed to deliver short-term therapy for pain relief. This system is effective for various types of pain, including post-surgical discomfort following procedures like knee replacements and thoracotomies, as well as neuropathic and musculoskeletal pain. In addition to the Smartpatch, SPR Therapeutics offers the Micropulse, an implantable PNS system for long-term therapy, and the Smartpatch MicroLead, which promotes rapid tissue ingrowth. By providing non-narcotic alternatives for pain management, SPR Therapeutics aims to offer safe and effective treatments that reduce reliance on opioid medications and invasive surgeries. The company was founded in 2009 and has additional facilities in the Carolina’s Research Triangle and Minneapolis, Minnesota.